PriceTargets.com logo

Impact Healthcare REIT - IHR Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 137.50
  • Forecasted Upside: 30.21%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 105.60 As of 01/27/2023 01:00 AM ET
▼ -0.2 (-0.19%)

This chart shows the closing price for IHR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Impact Healthcare REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IHR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IHR

Analyst Price Target is GBX 137.50
▲ +30.21% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Impact Healthcare REIT in the last 3 months. The average price target is GBX 137.50, with a high forecast of GBX 140 and a low forecast of GBX 135. The average price target represents a 30.21% upside from the last price of GBX 105.60.

This chart shows the closing price for IHR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in Impact Healthcare REIT. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/4/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/30/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/31/2022Berenberg BankReiterated RatingBuyGBX 135
5/13/2022Royal Bank of CanadaReiterated RatingOutperformGBX 140
4/12/2022Royal Bank of CanadaReiterated RatingOutperformGBX 135
4/8/2022Berenberg BankBoost TargetBuyGBX 125 ➝ GBX 135
3/24/2022Royal Bank of CanadaReiterated RatingOutperformGBX 135
3/11/2022Royal Bank of CanadaReiterated RatingOutperformGBX 135
5/6/2021Berenberg BankReiterated RatingBuyGBX 125
8/12/2020Berenberg BankReiterated RatingBuyGBX 110
5/12/2020Berenberg BankReiterated RatingBuyGBX 110
5/6/2020Berenberg BankReiterated RatingBuy
4/22/2020Berenberg BankReiterated RatingBuyGBX 110
2/6/2020Berenberg BankInitiated CoverageBuyGBX 130
(Data available from 1/29/2018 forward)

News Sentiment Rating

0.20 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/3/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/2/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/1/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2023

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Impact Healthcare REIT logo
Impact Healthcare REIT Plc is a real estate investment trust externally managed by Carne Global AIFM Solutions. The firm invests in the real estate markets of United Kingdom. It primarily acquires, owns, leases, renovates, extends and redevelops high quality healthcare real estate assets. Impact Healthcare REIT Plc was formed on 7 November 2016 and is based in London, United Kingdom.
Read More

Today's Range

Now: GBX 105.60
Low: 103.80
High: 105.60

50 Day Range

MA: GBX 104.03
Low: 100.60
High: 106.88

52 Week Range

Now: GBX 105.60
Low: 90.76
High: 128.20

Volume

238,076 shs

Average Volume

407,149 shs

Market Capitalization

£427.43 million

P/E Ratio

880.00

Dividend Yield

6.18%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Impact Healthcare REIT?

The following sell-side analysts have issued research reports on Impact Healthcare REIT in the last twelve months: Berenberg Bank, and Royal Bank of Canada.
View the latest analyst ratings for IHR.

What is the current price target for Impact Healthcare REIT?

2 Wall Street analysts have set twelve-month price targets for Impact Healthcare REIT in the last year. Their average twelve-month price target is GBX 137.50, suggesting a possible upside of 30.2%. Royal Bank of Canada has the highest price target set, predicting IHR will reach GBX 140 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of GBX 135 for Impact Healthcare REIT in the next year.
View the latest price targets for IHR.

What is the current consensus analyst rating for Impact Healthcare REIT?

Impact Healthcare REIT currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IHR will outperform the market and that investors should add to their positions of Impact Healthcare REIT.
View the latest ratings for IHR.

What other companies compete with Impact Healthcare REIT?

Other companies that are similar to Impact Healthcare REIT include Assura, Picton Property Income, Custodian Property Income REIT, Warehouse REIT and Mountview Estates. Learn More about companies similar to Impact Healthcare REIT.

How do I contact Impact Healthcare REIT's investor relations team?

The company's listed phone number is 44 20 7409 0181. The official website for Impact Healthcare REIT is www.impactreit.uk. Learn More about contacing Impact Healthcare REIT investor relations.